DNA-Based MXFs to Enhance Radiotherapy and Stimulate Robust Antitumor Immune Responses.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35344667.
- Also identified by DOI 10.1021/acs.nanolett.1c04888.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Metal "X" Frameworks (MXFs) constructed from metal ions and biomacromolecules ("X components") via coordination interactions show crystalline structures and diverse functionalities. Here, a series of MXFs composed of various metal ions (e.g., Zn<sup>2+</sup>, Hf<sup>4+</sup>, Ca<sup>2+</sup>) and DNA oligodeoxynucleotides were reported. With MXF consisting of Hf<sup>4+</sup> and CpG oligodeoxynucleotides as the example, we show that such Hf-CpG MXF can achieve high-Z elements-enhanced photon radiotherapy and further trigger robust tumor-specific immune responses, thus showing efficient tumor suppression ability. <i>In vivo</i> experiments showed that external beam radiotherapy applied on tumors locally injected with Hf-CpG MXF result in the thorough elimination of primary tumors, complete inhibition of tumor metastasis, and protection against tumor rechallenge by triggering robust antitumor immune responses. Our findings provide a blueprint for fabricating a variety of rationally designed MXFs with desired functions and present the strategy of stimulating whole-body systemic immune responses by only local treatment of radiotherapy.
Medical subject headings
- Immunotherapy
- Neoplasms